HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chitra Sarkar Selected Research

Transforming Growth Factors (Transforming Growth Factor)

1/2022Upregulation of Atypical Cadherin FAT1 Promotes an Immunosuppressive Tumor Microenvironment via TGF-β.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chitra Sarkar Research Topics

Disease

53Neoplasms (Cancer)
03/2022 - 08/2002
26Glioma (Gliomas)
05/2022 - 07/2003
24Glioblastoma (Glioblastoma Multiforme)
01/2022 - 03/2003
12Ependymoma
04/2021 - 10/2002
9Astrocytoma (Pilocytic Astrocytoma)
08/2022 - 03/2003
7Meningioma (Meningiomas)
12/2018 - 05/2005
7Medulloblastoma
03/2017 - 08/2002
5Hypoxia (Hypoxemia)
04/2021 - 08/2014
5Brain Neoplasms (Brain Tumor)
12/2018 - 10/2002
5Epilepsy (Aura)
11/2018 - 06/2015
5Inflammation (Inflammations)
10/2018 - 02/2004
4Oligodendroglioma
08/2018 - 06/2004
4Drug Resistant Epilepsy
10/2017 - 06/2006
4Seizures (Absence Seizure)
10/2017 - 02/2010
4Carcinoma (Carcinomatosis)
10/2015 - 04/2013
3Infections
01/2022 - 04/2003
3Focal Cortical Dysplasia
06/2020 - 09/2017
3Tuberous Sclerosis (Bourneville's Disease)
06/2020 - 01/2004
2COVID-19
01/2022 - 01/2022
2Primitive Neuroectodermal Tumors (PNET)
01/2021 - 11/2009
2Spinal Cord Diseases
01/2019 - 01/2011
2Hemangioma (Angioma)
01/2019 - 01/2011
2Hippocampal Sclerosis
10/2018 - 11/2017
2Microsatellite Instability
12/2017 - 01/2004
2Central Nervous System Neoplasms
11/2016 - 05/2005
2Necrosis
10/2014 - 04/2004
2Neurocytoma
12/2011 - 10/2006
2Muscular Dystrophies (Muscular Dystrophy)
07/2009 - 12/2004
2Dermatomyositis (Dermatopolymyositis)
01/2009 - 07/2007
1Bronchopneumonia
01/2022
1Cytokine Release Syndrome
01/2022
1Severe Acute Respiratory Syndrome
01/2022
1Acute Lung Injury
01/2022
1Coinfection
01/2022
1Intellectual Disability (Idiocy)
12/2019
1alpha-Thalassemia
12/2019

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2002
10MicroRNAs (MicroRNA)IBA
04/2021 - 04/2013
10DNA (Deoxyribonucleic Acid)IBA
04/2016 - 10/2002
8Biological ProductsIBA
05/2022 - 08/2002
7Messenger RNA (mRNA)IBA
08/2022 - 04/2003
7Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2014
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 04/2011
7ErbB Receptors (EGF Receptor)IBA
01/2016 - 06/2006
6Transcription Factors (Transcription Factor)IBA
07/2020 - 05/2012
6Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
12/2019 - 12/2010
6MethyltransferasesIBA
12/2017 - 12/2010
4CytokinesIBA
01/2022 - 03/2014
4Cadherins (E-Cadherin)IBA
01/2022 - 12/2016
4Histones (Histone)IBA
12/2019 - 12/2014
4RNA (Ribonucleic Acid)IBA
01/2016 - 05/2005
4Temozolomide (Temodar)FDA LinkGeneric
04/2015 - 12/2010
3InterleukinsIBA
01/2022 - 05/2005
3Small Interfering RNA (siRNA)IBA
01/2022 - 03/2014
3trans-sodium crocetinate (crocetin)IBA
06/2020 - 01/2004
3NestinIBA
05/2018 - 10/2014
3Enhancer of Zeste Homolog 2 ProteinIBA
12/2017 - 10/2015
2Long Noncoding RNAIBA
08/2022 - 07/2020
2LuciferasesIBA
04/2021 - 01/2018
2Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
01/2021 - 05/2018
2Ethanol (Ethyl Alcohol)IBA
01/2019 - 01/2011
2EnzymesIBA
12/2018 - 10/2008
2Transforming Growth Factor beta (TGF-beta)IBA
10/2018 - 04/2003
2GlycogenIBA
05/2018 - 01/2015
2VimentinIBA
01/2018 - 03/2014
2Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2018 - 07/2013
2Mucin-1 (CA 15-3 Antigen)IBA
01/2018 - 03/2014
2TOR Serine-Threonine KinasesIBA
09/2017 - 09/2016
22,6-dinitrotoluene (DNT)IBA
11/2016 - 04/2009
2Cyclin D1IBA
11/2016 - 06/2006
2Progesterone Receptors (Progesterone Receptor)IBA
10/2015 - 07/2014
2Amphotericin B (Amphotericin)FDA LinkGeneric
06/2015 - 01/2005
2SynaptophysinIBA
01/2015 - 01/2004
2Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
08/2009 - 05/2005
2Immunotoxins (Immunotoxin)IBA
08/2009 - 05/2005
2Cytotoxins (Cytolysins)IBA
08/2009 - 05/2005
2Protons (Proton)IBA
02/2003 - 02/2003
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
03/2022
1Calcitriol Receptors (Calcitriol Receptor)IBA
01/2022
1Mediator ComplexIBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1Viral ProteinsIBA
01/2022
1Angiotensin-Converting Enzyme 2IBA
01/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022
1Conditioned Culture MediaIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1Mitogen-Activated Protein KinasesIBA
12/2021
1CalciumIBA
04/2021
1Muramidase (Lysozyme)IBA
11/2020
1Genetic Markers (Genetic Marker)IBA
12/2019
1Amino AcidsFDA Link
12/2019

Therapy/Procedure

23Therapeutics
01/2022 - 08/2002
4Radiotherapy
03/2017 - 03/2011
4Craniotomy
05/2016 - 02/2009
3Drug Therapy (Chemotherapy)
03/2017 - 03/2011
3Decompression
09/2014 - 09/2005
2Laminectomy
01/2019 - 01/2011
2Surgical Decompression
01/2019 - 01/2011
2Adjuvant Radiotherapy
10/2013 - 10/2006
1Immunotherapy
10/2019